Skip to main content
. 2016 May 28;4:134–141. doi: 10.1016/j.pmedr.2016.05.003

Table 4.

Adjusted odds ratios and corresponding 95% confidence intervals of changes occurring in using drugs in early or young adulthood among respondents participating in the National Longitudinal Study of Adolescent Health (Add Health), 1994–2008.

Early adulthooda
Young adulthoodb
Marijuana
Illegal drug use
Cocaine
Marijuana
Illegal drugs
Cocaine
OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI) OR (95% CI)
Exposure changes in Waves 1–2
 Tobacco use
 Non-smokers Reference Reference Reference Reference Reference Reference
 Persistent smokers 1.96 (1.56, 2.45) 0.87 (0.57, 1.28) 1.28 (0.79, 2.08) 1.47 (1.17, 1.83) 3.28 (2.73, 3.94) 3.70 (3.09, 4.44)
 New onset 3.48 (1.22, 9.91) 6.73 (1.39, 32.61) 1.31 (0.28, 6.08) 0.67 (0.27, 1.69) 1.27 (0.59, 2.70) 1.54 (0.76, 3.11)
 Quitters 0.99 (0.71, 1.38) 0.29 (0.11, 0.78) 0.39 (0.16, 0.95) 0.91 (0.64, 1.28) 0.99 (0.72, 1.36) 0.93 (0.67, 1.29)
 Alcohol use
 Non-users Reference Reference Reference Reference Reference Reference
 Heavy drinkers 1.69 (1.21, 2.37) 0.45 (0.24, 0.86) 1.88 (0.92, 3.85) 0.96 (0.69, 1.33) 1.93 (1.45, 2.57) 1.56 (1.20, 2.04)
 Moderate users 1.30 (0.73, 2.32) 0.28 (0.11, 0.70) 0.99 (0.30, 3.24) 0.69 (0.38, 1.22) 1.96 (1.22, 3.13) 1.86 (1.18, 2.94)
 Fluctuate/relapse 1.18 (0.92, 1.92) 0.45 (0.16, 1.27) 0.89 (0.24, 3.24) 0.59 (0.35, 0.98) 1.33 (0.85, 2.09) 0.49 (0.30, 0.80)
 Marijuana use
 Non-users Reference Reference Reference Reference Reference Reference
 1–19 1.05 (0.59, 1.87) 1.31 (0.49, 3.55) 1.41 (0.38, 5.22) 2.50 (1.45, 4.31) 2.14 (1.30, 3.52) 2.50 (1.45, 4.31)
 ≥ 20 0.73 (0.28, 1.90) 0.92 (0.20, 4.21) 0.35 (0.06, 2.17) 1.20 (0.50, 2.86) 8.07 (4.10, 15.90) 1.20 (0.50, 2.86)
 Irregular (1 or ≥ 20) 1.10 (0.74, 1.64) 1.78 (0.82, 3.87) 0.89 (0.36, 2.18) 1.47 (1.02, 2.13) 1.94 (1.37, 2.74) 1.47 (1.02, 2.13)

Abbreviations: CI = confidence interval; OR, odds ratio; Add Health.

CES-D is Center for Epidemiologic Study of Depression Scale.

§Initial drug use refers to use of tobacco, alcohol, marijuana (gateway drugs) at baseline of the study, in the early adolescence. Reference group is non-users of a particular gateway drug at the respective developmental stage.

Adjusted for the following covariates at different exposures: age, gender, race,

a

Young adulthood (age groups 19-23 years).

b

Older adulthood (age groups 24-33 years).